Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 34.90
+0.40 (1.16%)
Jan 22, 2026, 1:07 PM CST
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 7.15 billion as of January 21, 2026. Its market cap has decreased by -19.54% in one year.
Market Cap
7.15B
Enterprise Value
8.05B
Revenue
649.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.90
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 7.15B, an increase of 1,123.83%. That is a compound annual growth rate of 15.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 7.15B | 9.18% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gongwin Biopharm Holdings | 9.67B |
| Acepodia | 8.59B |
| Adimmune | 8.49B |
| OBI Pharma | 6.80B |
| Savior Lifetec | 6.41B |
| Pharmosa Biopharm | 6.27B |
| CHO Pharma | 6.14B |
| Sinphar Pharmaceutical | 5.86B |